Clinical

Dataset Information

0

Pacritinib to Inhibit JAK/STAT Signaling in Refractory Colorectal Cancer


ABSTRACT: The investigators propose to assess the efficacy, progression-free survival, and adverse events of pacritinib in patients with refractory colorectal cancer.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2177220 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2021-09-09 | GSE183415 | GEO
| PRJNA663002 | ENA
| PRJNA663003 | ENA
2016-04-21 | GSE65622 | GEO
2024-07-30 | GSE273448 | GEO
2021-09-03 | GSE162117 | GEO
| PRJNA671240 | ENA
2024-08-28 | MSV000095718 | GNPS
| 2141562 | ecrin-mdr-crc
2020-11-26 | GSE141147 | GEO